Gujarat Alkalies & Chemicals Ltd
₹ 613
-3.36%
21 May
- close price
- Market Cap ₹ 4,502 Cr.
- Current Price ₹ 613
- High / Low ₹ 900 / 484
- Stock P/E 285
- Book Value ₹ 821
- Dividend Yield 0.00 %
- ROCE 0.89 %
- ROE 0.26 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.75 times its book value
- Company has been maintaining a healthy dividend payout of 229%
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 8.37% over past five years.
- Company has a low return on equity of 2.47% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,896 | 1,948 | 1,995 | 2,070 | 2,455 | 3,161 | 2,725 | 2,429 | 3,759 | 4,516 | 3,807 | 4,073 | |
| 1,522 | 1,674 | 1,660 | 1,621 | 1,668 | 2,046 | 2,147 | 2,071 | 2,772 | 3,402 | 3,671 | 3,712 | |
| Operating Profit | 374 | 274 | 335 | 450 | 787 | 1,115 | 578 | 358 | 987 | 1,115 | 136 | 360 |
| OPM % | 20% | 14% | 17% | 22% | 32% | 35% | 21% | 15% | 26% | 25% | 4% | 9% |
| 30 | 49 | 45 | 56 | 106 | 61 | 90 | 67 | 46 | 42 | 90 | 92 | |
| Interest | 6 | 9 | 10 | 13 | 15 | 21 | 14 | 15 | 6 | 19 | 45 | 51 |
| Depreciation | 151 | 98 | 107 | 111 | 127 | 140 | 162 | 174 | 198 | 276 | 377 | 392 |
| Profit before tax | 247 | 215 | 263 | 382 | 750 | 1,015 | 492 | 236 | 829 | 861 | -196 | 10 |
| Tax % | 25% | -6% | 16% | 19% | 29% | 32% | 32% | 29% | 32% | 33% | -32% | -63% |
| 185 | 228 | 220 | 308 | 535 | 690 | 333 | 167 | 562 | 576 | -132 | 16 | |
| EPS in Rs | 25.20 | 31.03 | 29.94 | 41.95 | 72.85 | 93.91 | 45.32 | 22.72 | 76.53 | 78.39 | -18.01 | 2.15 |
| Dividend Payout % | 16% | 14% | 15% | 12% | 9% | 9% | 18% | 35% | 13% | 30% | -77% | 733% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 8% |
| 3 Years: | 3% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -23% |
| 5 Years: | -46% |
| 3 Years: | -70% |
| TTM: | 112% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 14% |
| 3 Years: | -12% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 4% |
| 3 Years: | 2% |
| Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 |
| Reserves | 1,890 | 2,063 | 2,855 | 3,283 | 3,749 | 4,223 | 4,524 | 5,304 | 5,831 | 6,237 | 6,278 | 5,953 |
| 220 | 158 | 295 | 353 | 291 | 247 | 205 | 498 | 594 | 597 | 544 | 561 | |
| 648 | 693 | 671 | 726 | 859 | 988 | 1,090 | 1,282 | 1,484 | 1,599 | 1,404 | 1,756 | |
| Total Liabilities | 2,831 | 2,988 | 3,895 | 4,437 | 4,972 | 5,532 | 5,893 | 7,157 | 7,983 | 8,506 | 8,299 | 8,343 |
| 1,615 | 1,656 | 1,821 | 2,073 | 2,104 | 2,300 | 2,610 | 2,587 | 2,702 | 4,250 | 4,617 | 4,584 | |
| CWIP | 30 | 67 | 83 | 151 | 252 | 307 | 445 | 1,109 | 1,787 | 544 | 95 | 79 |
| Investments | 182 | 193 | 855 | 1,017 | 1,147 | 1,066 | 1,244 | 2,095 | 2,115 | 2,002 | 2,369 | 2,332 |
| 1,005 | 1,072 | 1,136 | 1,195 | 1,469 | 1,858 | 1,594 | 1,366 | 1,379 | 1,710 | 1,218 | 1,348 | |
| Total Assets | 2,831 | 2,988 | 3,895 | 4,437 | 4,972 | 5,532 | 5,893 | 7,157 | 7,983 | 8,506 | 8,299 | 8,343 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 242 | 295 | 201 | 503 | 515 | 838 | 630 | 421 | 735 | 960 | 67 | 381 | |
| -167 | -212 | -352 | -468 | -395 | -581 | -634 | -334 | -804 | -662 | -90 | -264 | |
| -90 | -88 | 84 | 13 | -116 | -136 | -146 | 226 | 12 | -140 | -277 | -145 | |
| Net Cash Flow | -14 | -5 | -67 | 49 | 3 | 122 | -150 | 313 | -58 | 158 | -301 | -28 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 57 | 60 | 58 | 60 | 56 | 50 | 43 | 29 | 23 | 17 | 24 |
| Inventory Days | 105 | 96 | 99 | 94 | 147 | 99 | 92 | 88 | 101 | 111 | 93 | 110 |
| Days Payable | 95 | 119 | 99 | 125 | 154 | 134 | 126 | 111 | 101 | 119 | 86 | 115 |
| Cash Conversion Cycle | 69 | 34 | 60 | 27 | 53 | 22 | 17 | 21 | 29 | 15 | 25 | 19 |
| Working Capital Days | 89 | 47 | 90 | 83 | 99 | 96 | 107 | 20 | 8 | 16 | 18 | 21 |
| ROCE % | 12% | 10% | 10% | 11% | 18% | 24% | 11% | 5% | 14% | 13% | -2% | 1% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
2d - Annual Secretarial Compliance Report for FY 2024-25 confirming regulatory adherence.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 May - Newspaper Clippings of the extract of Standalone & Consolidated audited Financial Results for the Fourth Quarter and Financial Year ended on 31st March 2025.
-
Installation Of 90-120 MTPD HCL Synthesis Unit
16 May - Approved Rs.35 Cr capex for 90-120 MTPD HCL synthesis unit at Dahej for captive use.
-
Intimation Of Installation Of Plants To Produce Downstream Products Of Chlorotoluenes
16 May - Approved Rs.81 Cr capex for 3 Chlorotoluenes plants, 40 TPD capacity, Rs.156 Cr expected annual revenue.
-
Announcement under Regulation 30 (LODR)-Change in Management
16 May - Appointment of Shri S J Haider, IAS as Additional Director effective 16 May 2025, subject to shareholder approval.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Concalls
-
Feb 2025TranscriptNotesPPT
-
Jun 2024TranscriptNotesPPT
-
Mar 2024TranscriptNotesPPT
-
Dec 2023TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Jun 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Jun 2019TranscriptNotesPPT
-
Mar 2017TranscriptNotesPPT
-
May 2016TranscriptPPT
Product Offerings
The company has over 36 products in its portfolio, including Caustic Soda lye, flakes, and prills, Chloromethanes, Liquid Chlorine, Hydrochloric Acid, Hydrogen Peroxide, Anhydrous Aluminum Chloride, Caustic Potash lye and flakes, Potassium Carbonate granules and powder, Aluminium Chloride, Phosphoric Acid, etc. These products are utilized across industries such as textiles, pulp and paper, alumina, soaps& detergents, and water treatment, etc. [1]